GlassScriptPhysician profile
Delane Price
NPI 1720025729
$619.26
in general payments reported to CMS, 2019-2025
10 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.62 · 2022: $29.19 · 2023: $63.91 · 2024: $205 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $204.24 | 2021-2025 | |
| Harmony Biosciences LLC | $152.21 | 2024-2025 | |
| Glaxosmithkline, LLC. | $56.46 | 2025 | Nucala |
| Inspire Medical Systems, INC. | $40.79 | 2023 | Inspire |
| Genzyme Corporation | $36.64 | 2021 | |
| Axsome Therapeutics, INC. | $35.84 | 2025 | Sunosi |
| Pinnacle Biologics, INC | $29.19 | 2022 | |
| Medtronic, INC. | $23.12 | 2023 | Nuvent |
| Lilly USA, LLC | $22.51 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $18.26 | 2025 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delane Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.